Disclosures for "Factors Associated with Poor Outcomes in Reversible Cerebral Vasoconstriction Syndrome: A Seven-year Study at a Comprehensive Stroke Center"
-
Ms. McGraw has nothing to disclose.
-
Dr. Peralta has nothing to disclose.
-
Dr. Pirahanchi has nothing to disclose.
-
Dr. Burrell has nothing to disclose.
-
Amy Nieberlein has nothing to disclose.
-
David Bar-Or has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ampio Pharmaceuticals. David Bar-Or has stock in Ampio Pharmaceuticals.
-
Dr. Bartt has nothing to disclose.